Clinical investigation of medicinal products in the treatment of depression

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberCHMP/185423/2010 Rev. 2
Published30/05/2013
Effective from01/12/2013
KeywordsMajor depression, major depressive episode, partial response, treatment resistance, suicidal thoughts, suicidal behaviour, suicide, acute treatment, maintenance treatment, recurrence prevention
DescriptionThis document provides guidance on the development of medicinal products for acute and long-term treatment of major depressive disorder


Document history

Revision 3

In progress

Concept paper

Published: 18/11/2016
 

Deadline for comments: 28/02/2017

Revision 2 

Current version

Adopted guideline


Draft guideline


Concept paper

In operation: 01/12/2013–present


Published: 11/10/2011


Published: 19/02/2009

Revision 1 Adopted guidelineIn operation: 01/10/2002–30/11/2013


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more